A clinical research study for Parkinson’s Disease (PD)
Summary
A clinical research study to evaluating the safety and effectiveness of an
investigational drug(oral UCB0599) in study participants diagnosed with early-stage Parkinson's Disease
Eligibility
Eligible gender: Male, Female
Eligible ages: 40 to 70
Inclusion criteria:
You may be eligible to participate in this trial if you are:
- 40 to 75 years of age
- have been diagnosed with early Parkinson’s Disease (PD)
Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion criteria:
You may not be eligible to participate in this trial if you:
- have hypersensitivity to UCB0599
- female who is breastfeeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.
Participate
Additional information
Contact information
Please contact study coordinator Wilna Bouwer at Wilna.Bouwer@ucalgary.ca or 403.630.8250 if you would like to learn more about this trial.
Principal investigator:
Davide Martino
Clinical trial:
Yes
REB-ID:
REB21-0071